Earnings and Growth Analysis : Neos Therapeutics (NASDAQ:NEOS)

Earnings results for Neos Therapeutics (NASDAQ:NEOS)

Neos Therapeutics, Inc. is expected* to report earnings on 11/09/2020 before market open. The report will be for the fiscal Quarter ending Sep 2020. The reported EPS for the same quarter last year was $-0.04.

Neos Therapeutics last announced its quarterly earnings data on August 10th, 2020. The reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.02. The firm had revenue of $13.13 million for the quarter. Neos Therapeutics has generated ($0.34) earnings per share over the last year. Neos Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, November 9th, 2020.

Analyst Opinion on Neos Therapeutics (NASDAQ:NEOS)

There is not enough analysis data for Neos Therapeutics.

Dividend Strength: Neos Therapeutics (NASDAQ:NEOS)

Neos Therapeutics does not currently pay a dividend. Neos Therapeutics does not have a long track record of dividend growth.

Insiders buying/selling: Neos Therapeutics (NASDAQ:NEOS)

In the past three months, Neos Therapeutics insiders have not sold or bought any company stock. Only 3.80% of the stock of Neos Therapeutics is held by insiders. 35.98% of the stock of Neos Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Neos Therapeutics (NASDAQ:NEOS

Earnings for Neos Therapeutics are expected to grow in the coming year, from ($0.28) to ($0.06) per share. The P/E ratio of Neos Therapeutics is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Neos Therapeutics is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

More latest stories: here